Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Telios Pharma stands as a privately owned clinical-stage biopharmaceutical firm, pioneering first-in-class topical and oral BTK inhibitor programs with a focus on combating mast cell-mediated inflammation and allergy. Established in 2019 by seasoned industry professionals, Telios Pharma has assembled a cadre of scientists and clinicians boasting profound therapeutic knowledge alongside a skilled leadership ensemble. Fueled by ...
Telios Pharma stands as a privately owned clinical-stage biopharmaceutical firm, pioneering first-in-class topical and oral BTK inhibitor programs with a focus on combating mast cell-mediated inflammation and allergy. Established in 2019 by seasoned industry professionals, Telios Pharma has assembled a cadre of scientists and clinicians boasting profound therapeutic knowledge alongside a skilled leadership ensemble. Fueled by passion, collaboration, and an unwavering dedication to our mission, we strive to enhance the quality of life for patients grappling with inflammatory diseases.

List your booth number for exhibitions, ask us